GTR 90582797
Bids Are Invited For Acquisition Of Chemotherapy Medicines
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
90582797
Tendering Authority
Subscribe to view
Tender No
90128/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Chemotherapy Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
13-01-2025
Closed
Work Detail
Folinic Acid / Calcium Folinate 10Mg/Ml 30Ml [1 Milliliters; Injectable Solution], Folinic Acid / Calcium Folinate 15Mg, Alfainterferon 2B 5 Mui [Injectable Solution Powder], Anastrozole 1Mg, Bicalutamide 50Mg, Bleomycin, Sulfate 15 Iu [Injectable Solution Powder], Bortezomib 3.5Mg [Cx C/1; Po Injectable Solution/], Brentuximab Vedotin 50Mg [Po Injectable Solution], Capecitabine 500Mg, Carboplatin 450Mg [Po Injectable Solution], Cyclophosphamide 1000 Mg [Po Injectable Solution], Cisplatin 1 Mg/Ml 50 Ml [Injectable Solution], Cytarabine 100Mg/Ml 5Ml [Injectable Solution], Chlorambucil 2Mg, Dacarbazine 200Mg [Po Injection Solution], Daunorubicin, 20Mg Hydrochloride [Po Injectable Solution], Dexrazoxane, 500Mg Hydrochloride [Po Injectable Solution], Docetaxel 80Mg Tri-Hydrate Solution Ready To Use [Po Solution For Injection], Doxorubicin, Hydrochloride 2Mg/Ml 10Ml [Injectable Suspension], Hydrochloride 50Mg [Po Solution For Injection], Epirubicin, Hydrochloride 2Mg/Ml 25Ml [Injectable Solution], Recombinant Human Erythropoietin 40,000Ui/Ml 1Ml [Injectable Solution], Erlotinib, 150Mg Hydrochloride, Etoposide 20Mg/Ml 5Ml [Injectable Solution], Everolimus 10Mg, Exemestane 25Mg, Filgrastin 300 Mcg, 0.5Ml, Inj., Fluorouracil 50 Mg/Ml 50 Ml [Injectable Solution], Fulvestrant 50Mg/Ml 5Ml [Injectable Solution], Ganciclovir Sodium 1Mg/Ml 250 Ml [Injectable Solution], Gefitinib 250Mg, Gemcitabine 1000Mg [Po Injectable Solution], Hydroxyurea 500Mg, Ifosfamide 2000 Mg [Po Injectable Solution], Irinotecan, Hydrochloride 20Mg/Ml 5Ml [Injectable Solution], Leuprorelin, Acetate 22.5 Mg [Po Injectable Solution], Acetate 45 Mg [Po Injectable Solution], Melphalan 2Mg, Mercaptopurine 50Mg, Mesna 100Mg/Ml 4 Ml [Injectable Solution], Methotrexate 2.5Mg, Methotrexate 500Mg [Po Injectable Solution], Mitoxantrone, Hydrochloride 2Mg/Ml 10Ml [Injectable Solution], Oxaliplatin 100 Mg [Po Injectable Solution], Paclitaxel6mg/Ml50ml[Injectable Solution], Panitumumab 100Mg, Injectable, Pazopanib, Hydrochloride200mg, Hydrochloride400mg, Sunitinib, Maleate 12, Maleate 25Mg, Maleate 50Mg, Tamoxifen, Citrate 20Mg, Temozolomide 100Mg, Temozolomide 20Mg, Temozolomide 5Mg, Topotecan, Hydrochloride 4Mg [Powder Injectable Solution], Vinblastine, Sulfate 1Mg/Ml 10Ml [Injectable Solution], Vincristine, Sulfate 1Mg/Ml1ml [Injectable Solution], Vinorelbine 20Mg, Vinorelbine 30Mg, Vinorelbine, Dictartrate 10Mg/Ml5ml [Injectable Solution], Rituximab 10Mg/Ml Iv 10Ml, Rituximab 10Mg/Ml Iv 50Ml
Key Value
Tender Value
18,471,915 - BRL
Tender Documents
Global Tender Document
7d39c94d-f468-49a0-af50-9d1f1dd2c19a.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.